Effectiveness of Individualized Pelvic Floor Muscle Rehabilitation in Addition to Standard Urotherapy and Alarm Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis

Condition(s) studied

Investigational drug(s) / intervention(s)

Standard urotherapy, Alarm therapy: Participants will receive standard urotherapy and alarm therapy for 12 weeks.

Standard urotherapy, Alarm therapy, Individualized pelvic floor muscle rehabilitation: Participants will receive standard urotherapy, alarm therapy, and pelvic floor muscle rehabilitation for 12 weeks.

Study summary

This study will evaluate whether adding individualized pelvic floor muscle rehabilitation to standard urotherapy and alarm treatment improves bedwetting in children aged 5-18 years with primary monosymptomatic nocturnal enuresis.

Participants will be randomly assigned to two groups. Both groups will receive standard urotherapy and alarm treatment. One group will also receive pelvic floor muscle rehabilitation for 12 weeks. The study will compare dry nights, alarm activations, and changes in pelvic floor muscle function between the groups.

Eligibility

Primary outcome measure(s)

• Number of Dry Nights — Baseline and weeks 4, 8, and 12.
  The number of nights without involuntary urine leakage during sleep will be recorded by parents using an enuresis diary.
• Number of Enuresis Alarm Activations — Baseline and weeks 4, 8, and 12.
  The number of moisture-triggered enuresis alarm activations during sleep will be recorded by parents using an enuresis diary.

Trial sites (1)

More Hacettepe University trials in Turkey